Four batches of EpiPens have been recalled.
Affected batch numbers are 5FA665, 5FA6651, 5FA6652, and 5FA6653, all of which expire in April, 2017.
“It has been identified that EpiPens from the four affected batches may contain a defective part that could result in the auto-injector failing to activate or a need to apply more force than normal to activate,” a statement from the Therapeutic Goods Administration said.
“If your EpiPen is from batch 5FA665, 5FA6651, 5FA6652 or 5FA6653 … return it to your pharmacy.”
EpiPens are used to treat people who go into anaphylaxis due to severe allergic reactions.